2022 NCCP 临床指南:妊娠滋养细胞疾病(GTD)患者的诊断、分期和治疗

2022-05-13 NCCP,National Cancer Control Programme 国家癌症控制计划 hse.ie

2022 NCCP 临床指南:妊娠滋养细胞疾病(GTD)患者的诊断、分期和治疗

中文标题:

2022 NCCP 临床指南:妊娠滋养细胞疾病(GTD)患者的诊断、分期和治疗

英文标题:

Diagnosis, staging and treatment of patients with gestational trophoblastic disease

发布日期:

2022-05-13

简要介绍:

2022 NCCP 临床指南:妊娠滋养细胞疾病(GTD)患者的诊断、分期和治疗

相关资料下载:
[AttachmentFileName(sort=1, fileName=national-clinical-guideline-gtd-2022-.pdf)] GetToolGuiderByIdResponse(projectId=1, id=1d2dc1c0025e764c, title=2022 NCCP 临床指南:妊娠滋养细胞疾病(GTD)患者的诊断、分期和治疗, enTitle=Diagnosis, staging and treatment of patients with gestational trophoblastic disease, guiderFrom=hse.ie, authorId=0, author=, summary=2022 NCCP 临床指南:妊娠滋养细胞疾病(GTD)患者的诊断、分期和治疗, cover=https://img.medsci.cn/20220809/1660035086608_1608702.jpg, journalId=0, articlesId=null, associationId=3062, associationName=NCCP,National Cancer Control Programme 国家癌症控制计划, associationIntro=癌症的预防、诊断和治疗是一项重大的医疗保健挑战。国家癌症控制计划与卫生服务提供者合作,通过将通过研究、监测和结果评估获得的知识转化为战略和行动来预防癌症、治疗癌症并提高癌症患者的生存率和生活质量。, copyright=0, guiderPublishedTime=Fri May 13 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p>2022 NCCP 临床指南:妊娠滋养细胞疾病(GTD)患者的诊断、分期和治疗</p>, tagList=[TagDto(tagId=37155, tagName=妊娠滋养细胞疾病)], categoryList=[CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=304, categoryName=罕见病, tenant=100), CategoryDto(categoryId=21072, categoryName=罕见病网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4347, appHits=82, showAppHits=0, pcHits=236, showPcHits=4248, likes=0, shares=17, comments=2, approvalStatus=1, publishedTime=Mon Aug 15 16:30:00 CST 2022, publishedTimeString=2022-05-13, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=6, createdBy=null, createdName=dajiong, createdTime=Tue Aug 09 16:51:14 CST 2022, updatedBy=6459136, updatedName=艺玮, updatedTime=Thu Jan 04 02:27:36 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=national-clinical-guideline-gtd-2022-.pdf)])
national-clinical-guideline-gtd-2022-.pdf
下载请点击:
评论区 (1)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1238867, encodeId=dfc3123886ec2, content=妊娠滋养细胞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1208277490, createdName=ms5000001509268744, createdTime=Mon Aug 15 20:41:42 CST 2022, time=2022-08-15, status=1, ipAttribution=)]
    2022-08-15 ms5000001509268744

    妊娠滋养细胞

    0